Maximizing surgical outcomes with gender affirming hormone therapy in gender affirmation surgery

IF 4.2 Q1 ENDOCRINOLOGY & METABOLISM Journal of Clinical and Translational Endocrinology Pub Date : 2024-06-01 DOI:10.1016/j.jcte.2024.100355
Desha Gelles-Soto , Danielle Ward , Taylor Florio , Konstantinos Kouzounis , Christopher J. Salgado
{"title":"Maximizing surgical outcomes with gender affirming hormone therapy in gender affirmation surgery","authors":"Desha Gelles-Soto ,&nbsp;Danielle Ward ,&nbsp;Taylor Florio ,&nbsp;Konstantinos Kouzounis ,&nbsp;Christopher J. Salgado","doi":"10.1016/j.jcte.2024.100355","DOIUrl":null,"url":null,"abstract":"<div><p>Gender Affirmation Surgery (GAS) is a super specialized subset within the field of plastic and reconstructive surgery (PRS) that is ever evolving and of increasing interest to the PRS community. It is a multifaceted process which, in addition to surgical therapy, involves mental health therapy and hormonal therapy. One rapidly emerging interest within GAS is the role that gender affirming hormone therapy (GAHT) plays in enhancing surgical outcomes. GAHT has been used adjunctively with GAS as a comprehensive therapy to ameliorate gender dysphoria. This literature review will examine the positive effects of GAHT on the surgical outcomes on GAS, as well as other important considerations prior to surgery. As such, the primary objective of this literature review is to evaluate and assess the current evidence concerning the efficacy and safety of GAHT, as it relates to Gender Affirmation Surgery procedures.</p></div>","PeriodicalId":46328,"journal":{"name":"Journal of Clinical and Translational Endocrinology","volume":null,"pages":null},"PeriodicalIF":4.2000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2214623724000267/pdfft?md5=a2ccc9a180e1d6e22273188733ad8f53&pid=1-s2.0-S2214623724000267-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical and Translational Endocrinology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2214623724000267","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Gender Affirmation Surgery (GAS) is a super specialized subset within the field of plastic and reconstructive surgery (PRS) that is ever evolving and of increasing interest to the PRS community. It is a multifaceted process which, in addition to surgical therapy, involves mental health therapy and hormonal therapy. One rapidly emerging interest within GAS is the role that gender affirming hormone therapy (GAHT) plays in enhancing surgical outcomes. GAHT has been used adjunctively with GAS as a comprehensive therapy to ameliorate gender dysphoria. This literature review will examine the positive effects of GAHT on the surgical outcomes on GAS, as well as other important considerations prior to surgery. As such, the primary objective of this literature review is to evaluate and assess the current evidence concerning the efficacy and safety of GAHT, as it relates to Gender Affirmation Surgery procedures.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在性别确认手术中使用性别确认激素疗法,最大限度地提高手术效果
性别肯定手术(GAS)是整形与重建外科(PRS)领域中的一个超级专业分支,它不断发展,并日益受到整形与重建外科界的关注。它是一个多方面的过程,除了手术治疗外,还涉及心理健康治疗和激素治疗。性别平权激素疗法(GAHT)在提高手术效果方面的作用是 GAS 中迅速兴起的一个关注点。性别平权激素疗法与 GAS 作为一种综合疗法,被用于改善性别焦虑症。本文献综述将研究 GAHT 对 GAS 手术效果的积极影响,以及手术前的其他重要注意事项。因此,本文献综述的主要目的是评价和评估与性别确认手术相关的 GAHT 疗效和安全性方面的现有证据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.10
自引率
0.00%
发文量
24
审稿时长
16 weeks
期刊最新文献
The bio-artificial pancreas to treat type 1 diabetes: Perspectives from healthcare professionals in the Netherlands Clinical characteristics of Ketosis Prone Diabetes: Evaluating diagnosis and management practices in a real-life setting Association between incretin-based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: A large population-based matched cohort study Advances in nucleic acid delivery strategies for diabetic wound therapy Hyperandrogenic eumenorrheic NON-PCOS women versus women with PCOS after the GnRH-agonist stimulation test preceded by suppression of adrenal steroidogenesis with dexamethasone
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1